Fleur Harvey, The Royal Marsden NHS Foundation Trust, London, UK, discusses the launch of a self-administration service during COVID-19 with four agents (cytarabine, bortezomib, trastuzumab, denosumab) at the Royal Marsden NHS Foundation Trust. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).